All-trans retinoic acid acts as a dual-purpose inhibitor of SARS-CoV-2 infection and inflammation
Juanjuan Huang,Yabo Fang,Runze Wu,Tingzheng Xia,Xuan Wang,Jiwei Jia,Guoqing Wang
DOI: https://doi.org/10.1016/j.compbiomed.2024.107942
IF: 7.7
2024-01-04
Computers in Biology and Medicine
Abstract:Coronavirus disease 2019 (COVID-19) was an epidemic that effected human health caused by SARS-CoV-2 infection. All-trans retinoic acid (ATRA) has anti-inflammatory capability. In this article, we evaluated the effectiveness and revealed the molecular mechanism of ATRA for treating SARS-CoV-2 using deep learning, in vitro studies, multi-scale molecular modeling, and network pharmacology. The DeepDTA model suggested that ATRA would be effective against COVID-19. In vitro studies confirmed the antiviral activity of ATRA. Subsequently, multi-scale molecular modeling indicated that ATRA could binding to angiotensin converting enzyme 2 (ACE2), 3C-like protease (3CLpro), RNA dependent RNA polymerase (RdRp), helicase, and 3′-to-5′ exonuclease by non-covalent interactions. Additionally, network pharmacology suggested that ATRA alleviated inflammatory response by regulating the IL-17 signaling pathway and binding with TNF, PTGS2, and MAPK1 directly. In summary, our findings provide the first evidence that ATRA suppresses the entry and replication of SARS-CoV-2, and regulates inflammatory response of host cells.
engineering, biomedical,computer science, interdisciplinary applications,mathematical & computational biology,biology